- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: anti CD20
Total 160248 results
-
AmgenCompletedLymphoma, Non-HodgkinItaly, Spain, United States, Korea, Republic of, Australia, Georgia, Canada, Japan, Bulgaria, India, Romania, Colombia, Mexico, Czechia, France, Germany, Greece, Israel, Poland, Ukraine
-
Hebei Yanda Ludaopei HospitalChina Immunotech (Beijing) Biotechnology Co., Ltd.Completed
-
Beijing Tsinghua Chang Gung HospitalChina Immunotech Pharmaceuticals Co.Ltd.Suspended
-
Instituto de Cardiología y Medicina Vascular Hospital...UnknownHeart Failure With Reduced Ejection Fraction
-
M.D. Anderson Cancer CenterBiogenTerminatedLymphomaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityCompletedRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic
-
Maria Sklodowska-Curie National Research Institute...KCRINot yet recruitingCD20-positive Acute Lymphoblastic LeukemiaPoland
-
GenmabAbbVieRecruitingSmall Lymphocytic Lymphoma | Richter's Syndrome | Relapsed/Refractory Chronic Lymphocytic LeukemiaUnited States, Belgium, Netherlands, Spain, Italy, Australia, Israel, France, Denmark, Czechia, Germany, United Kingdom
-
Chinese PLA General HospitalUnknownB Cell Lymphoma | B Cell LeukemiaChina
-
Probiomed S.A. de C.V.UnknownDiffuse Large B Cell LymphomaMexico
-
Shanghai Henlius BiotechWithdrawnCD20-positive Follicular Lymphoma, With Low Tumour Burden
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., LtdRecruiting
-
Southwest Hospital, ChinaUnknownLymphoma, Large B-Cell, Diffuse | Leukemia, Lymphocytic, Chronic, B-Cell | Lymphoma,MalignantChina
-
McGill University Health Centre/Research Institute...McGill UniversityTerminatedSafety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)Complex Regional Pain SyndromesCanada
-
Beijing Mabworks Biotech Co., Ltd.RecruitingFollicular Lymphoma and Marginal Zone LymphomaChina
-
GlaxoSmithKlineCompletedLeukaemia, Lymphocytic, Chronic and Lymphoma, FollicularJapan
-
Charite University, Berlin, GermanyCompletedPosttransplant Lymphoproliferative Disorder | PTLDAustralia, France, Germany, Sweden, Belgium, Italy, Poland
-
National Cancer Institute (NCI)CompletedChronic Lymphocytic Leukemia | Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic LeukemiaUnited States
-
Gilead SciencesCompletedNon-Hodgkin's Lymphoma | Lymphoma, Diffuse | Lymphoma, Diffuse, Mixed Lymphocytic-HistiocyticFrance, United Kingdom
-
Gilead SciencesTerminatedPurpura, Thrombocytopenic, Idiopathic | Autoimmune Thrombocytopenic Purpura | Purpura, Thrombocytopenic, AutoimmuneUnited States
-
Henan Cancer HospitalHenan Hualong Biotechnology CompanyUnknownRefractory | B-Cell Lymphoma Stage I | RelapsedChina
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, Chronic, Diffuse Large B-cell Lymphoma, Follicular LymphomaChina
-
Shanghai Tongji Hospital, Tongji University School...Shanghai AbelZeta Ltd.CompletedB Cell LymphomaChina
-
Heidelberg UniversityRecruitingEarly Stage Follicular Lymphoma WHO Grade 1/2 or 3aGermany
-
The Lymphoma Academic Research OrganisationActive, not recruitingAggressive Non-Hodgkin LymphomaFrance, Belgium
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMantle Cell Lymphoma | CCND1 Positive | CD20-Positive Neoplastic Cells Present
-
Zhejiang Teruisi Pharmaceutical Inc.RecruitingCD20-positive B-cell Non-Hodgkin LymphomaChina
-
GlaxoSmithKlineCompletedArthritis, RheumatoidRussian Federation, Australia, Belgium, Spain, United States, New Zealand, Italy, Poland, France
-
Applied Molecular EvolutionCompletedNon-Hodgkin's LymphomaUnited States
-
Emory UniversityNovartisTerminatedRecurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic LymphomaUnited States
-
Beijing Mabworks Biotech Co., Ltd.CompletedCD20-positive B Cell Non-Hodgkin LymphomaChina
-
Spectrum Pharmaceuticals, IncBayerCompleted
-
King's College LondonRoche Pharma AG; Medical Research CouncilCompletedKidney Transplantation | Graft Rejection | ImmunosuppressionUnited Kingdom
-
Acepodia Biotech, Inc.RecruitingFollicular Lymphoma | B-cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | DLBCL | Primary Mediastinal Large B Cell LymphomaUnited States, Taiwan
-
New York Medical CollegeRoswell Park Cancer InstituteRecruitingDiffuse Large B-Cell Lymphoma | Burkitt Lymphoma | Non-Hodgkin Lymphoma | Primary Mediastinal B-cell Lymphoma | CD20+ Lymphoblastic Lymphoma | Follicular Lymphoma, Grade IIIUnited States
-
Han weidongUnknown
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Fate TherapeuticsTerminatedLymphoma, B-Cell | Chronic Lymphocytic LeukemiaUnited States
-
Medical University of ViennaCompletedStage IV Melanoma | Stage III MelanomaAustria
-
Shanghai Public Health Clinical CenterUnknownTo Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma
-
Alexey Danilov, MDGilead Sciences; Oregon Health and Science UniversityCompletedAnemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Lymphoplasmacytic Lymphoma | Recurrent Small Lymphocytic Lymphoma | Refractory Chronic Lymphocytic Leukemia | Hairy Cell Leukemia | Richter Syndrome | Recurrent Chronic Lymphocytic Leukemia | Refractory Small Lymphocytic Lymphoma | Grade 1 Follicular... and other conditionsUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon-hodgkin's LymphomaChina
-
Genor Biopharma Co., Ltd.RecruitingCLL | B Cell NHLAustralia
-
BayerCompletedNon-Hodgkin's Lymphoma (NHL)Japan
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's Hospital; University of Rochester and other collaboratorsCompletedNon-Hodgkin's LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityEnrolling by invitationRelapsed or Refractory B-cell Non-Hodgkin LymphomaChina
-
The Lymphoma Academic Research OrganisationCompletedNon Previously Treated CD20+ Diffuse Large B-cell LymphomaBelgium, France
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia